We should prohibit warfarin in idiopathic pulmonary fibrosis

Am J Respir Crit Care Med. 2015 Apr 15;191(8):958-60. doi: 10.1164/rccm.201412-2281LE.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use
  • Atrial Fibrillation / complications*
  • Atrial Fibrillation / drug therapy*
  • Fatal Outcome
  • Humans
  • Idiopathic Pulmonary Fibrosis / complications*
  • Male
  • Middle Aged
  • Thrombophlebitis / complications*
  • Thrombophlebitis / drug therapy*
  • Warfarin / adverse effects*

Substances

  • Anticoagulants
  • Warfarin